Why the study?
Are inflammatory biomarkers associated with pulmonary hypertension severity in adults with advanced heart failure?
Are inflammatory biomarkers associated with pulmonary hypertension severity in adults with advanced heart failure?
Inflammatory biomarkers, particularly IL-6, correlate with pulmonary hypertension severity and predict systolic pulmonary artery pressure in patients with advanced heart failure.
Answers are grounded in this paper and cite their sources.
IL-6 may mark PH severity in advanced HF; leaves open whether inflammation-targeted therapies alter outcomes.
CONTEXT: Inflammatory, endothelial and neurohormonal biomarkers are involved in heart failure (HF) and pulmonary hypertension (PH) pathogenesis. OBJECTIVE: To study these biomarkers in PH due to advanced HF. MATERIALS AND METHODS: Thirty adults with HF were included. Interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), high-sensitivity C-reactive protein (hsCRP), endothelin-1 and N-terminal prohormone of brain natriuretic peptide (NT-proBNP) were measured in peripheral vein and pulmonary artery during right heart catheterisation. RESULTS: IL-6, TNF-α, hsCRP and NT-proBNP correlated with pulmonary pressures independent of ventricular function, HF etiology and vascular bed. IL-6 was independent predictor of systolic pulmonary artery pressure (sPAP). DISCUSSION AND CONCLUSION: Inflammatory biomarkers correlate to PH severity. IL-6 predicts sPAP in advanced HF.
No takes yet. Share an insight, caveat, or question.
Dolenc et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: